Работы, на которые ссылается эта работа

Работ: 206

Работа: Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders

The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5
Обзорная статья2025Цитирований: 7
ABI
Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies
Ding-Ya Sun, Yijie Hu, Xin Li +3
Обзорная статья2024Цитирований: 7
ABI
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Xinyi Xiao, Shengkang Huang, Sifei Chen +4
Обзорная статья2021Цитирований: 5
ABI
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25
Статья2021Цитирований: 5
ABI
Multidrug resistance in cancer: role of ATP–dependent transporters
Michael M. Gottesman, Tito Fojo, Susan E. Bates
Обзорная статья2002Цитирований: 4
ABI
AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisions
Chou‐Yi Hsu, Shavan Askar, Samer Saleem Alshkarchy +7
СтатьяRadiomics and Machine Learning in Medical ImagingClinical and Experimental Medicine2025Цитирований: 3
ABI
Harnessing bacteria for tumor therapy: Current advances and challenges
Lina Guo, Jinsong Ding, Wenhu Zhou
Статья2023Цитирований: 3
ABI
Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple Myeloma
Sylvain Simon, Stanley R. Riddell
Другое2020Цитирований: 3
ABI
Precision sniper for solid tumors: CAR-NK cell therapy
Sisi Li, Jiajie Jing, Yueming Chen +6
Обзорная статья2025Цитирований: 3
ABI
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani +33
Статья2021Цитирований: 3
ABI
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos +80
Обзорная статья2022Цитирований: 3
ABI
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
Margot J. Pont, Tyler Hill, Gabriel O. Cole +14
Статья2019Цитирований: 2
ABI
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies
Annamaria Salvati, Viola Melone, Alessandro Giordano +12
Обзорная статья2025Цитирований: 2
ABI
GPRC5D-Targeted CAR T Cells for Myeloma
Sham Mailankody, Sean M. Devlin, Jonathan Landa +35
Статья2022Цитирований: 2
ABI
Off-the-Shelf Chimeric Antigen Receptor T Cells
Norihiro Watanabe, Maksim Mamonkin
Обзорная статья2021Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 2
ABI
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Michèle Cavo, Evangelos Terpos, Cristina Nanni +25
Обзорная статья2017Цитирований: 2
ABI
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Sumin Jo, Shipra Das, Alan F. Williams +19
Статья2022Цитирований: 2
ABI
Liquid chromatography–tandem mass spectrometry for clinical diagnostics
Stefani N. Thomas, Deborah French, Paul J. Jannetto +2
Обзорная статья2022Цитирований: 2
ABI
Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
Robert A. Kyle, Ellen D. Remstein, Terry M. Therneau +9
Статья2007Цитирований: 2
ABI
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
Joaquín Martínez‐López, Juan José Lahuerta, François Pépin +21
Статья2014Цитирований: 2
ABI
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau +7
Статья2005Цитирований: 2
ABI
High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes
Yinlei Bai, Kwan Yeung Wong, Tsz Kin Fung +1
Другое2016Цитирований: 2
ABI
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
Leo Rasche, Shweta S. Chavan, Owen Stephens +19
Статья2017Цитирований: 2
ABI
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elı́as Campo, Elaine S. Jaffe, James R. Cook +70
Статья2022Цитирований: 2
ABI